Cognitive Dysfunction
Reference List

1. Armstrong, C., Stern, C. & Corn, B. (2001). Memory performance used to detect radiation effects on cognitive functioning. Applied Neuropsychology, 8, 129-139.
2. Armstrong, C.L., Gyato, K., Awadalla, A.W., Lustig, R. & Tochner, Z.A. (2004). A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsychology Review, 14, 65-86
3. Breitbart, W., Bruera, E., Chochinov, H. & Lynch, M. (1995). Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. Journal of Pain and Symptom Management, 10, 131-141.
4. Brown, S. & Degner, L. (2001). Delirium in the terminally ill cancer patient: Aetiology, symptoms and management. International Journal of Palliative Nursing, 7, 266-272.
5. Butler, R. & Copeland, D. (2002). Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. Journal of the International Neuropsychological Society, 8, 115-124.
6. Capuron, L., Ravaud, A. & Dantzer, R. (2001). Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosomatic Medicine, 63, 376-386.
7. Folstein, M., Folstein, S. & McHugh, P. (1975). Mini-Mental State: A practical method for grading the state of patients for the clinician, Journal of Psychiatric Research, 12, 189-198.
8. Green, H., Pakenham, K., Headley, B., Yaxley, J., Nicol, D., Mactaggart, P., Swanson, C., Watson, R. & Gardiner, R. (2002). Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. International British Journal of Urology, 90, 427-432.
9. Harder, H., Cornelissen, J., Van Gool, A., Duivenvoorden, H., Eijkenboom, W. & van den Bent, M. (2002). Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer, 95, 183-192.
10. Katzman, R., Brown, T., Fuld, P., Peck, A., Schechter, R., & Schimmel, H. (1983). Validation of a short orientation-memory-concentration test of cognitive impairment. American Journal of Psychiatry, 140, 734-39.
11. Komaki ,R., Meyers, C., Shin, D. (1995). Evaluation of cognitive function in patients with limited small-cell lung cancer prior to and shortly following prophylactic cranial irradiation. International Journal of Radiation Oncology Biology and Physics, 33, 179-182.
12. Lawlor, P. (2002). The panorama of opioid -related cognitive dysfunction in patients with cancer: A critical literature appraisal. Cancer, 94, 1836-1863.
13. Lacosta, S., Merali, Z. & Anisman, H. (1999). Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors and anxiety. Behavioral Neuroscience, 113, 1030-1041.
14. Manne, S., Glassman, M. & DuHamel, K. (2001). Intrusion, avoidance, and psychological distress among individuals with cancer. Psychosomatic Medicine, 63, 658-667.
15. Mazzocato, C., Stiefel, F., Buclin, T. & Berney, A. (2000). Psychopharmacology in supportive care of cancer: A review for the clinician. II. Neuroleptics. Supportive Cancer Care, 8, 89-97.
16. Meyers, C. & Abbruzzese, J. (1992). Cognitive functioning in cancer patients: Effect of previous treatment. Neurology, 42, 434-436.
17. Olin, J. (2001). Cognitive function after systemic therapy for breast cancer. Oncology, 15, 613-624.
18. Pfeiffer, E. (1975). A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. Journal of American Geriatrics Society. 23, 433-41.
19. Poppelreuter, M., Weis, J., Kulz, A.K., Tucha, O., Lange, K.W. & Bartsch, H.H. (2004). Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. European Journal of Cancer, 40, 43-9
20. Rampersaud, G.C., Kauwell, G.P. & Bailey, L.B. (2003). Folate: A key to optimizing health and reducing disease risk in the elderly. Journal of the American College of Nutrition, 22, 1-8
21. Rugo, H.S. & Ahles, T. (2003). The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research. Seminars in Oncology, 30, 749-62
22. Saykin, A.J., Ahles, T.A.& McDonald, B.C. (2003). Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Seminars in Clinical Neuropsychiatry; 8, 201-16.
23. Schagen, S., Hamburger, H., Muller, M., Booerd, W. & van Dam, F. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. Journal of Neurooncology, 51, 159-162.
24. Sherer, M., Meyers, C. & Bergloff, P. (1997). Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer, 80, 250-257.
25. Taphoorn, M.J. & Klein, M. (2004). Cognitive deficits in adult patients with brain tumours. Lancet Neurology, 3, 159-68.
26. Tuma, R. & DeAngelis, L. (2000). Altered mental status in patients with cancer. Archives of Neurology, 57, 1727-1731.
27. van Dam, F., Schagen, S., Muller, M. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose vs standard dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
28. van Dam, F., Schagen, S., Muller, M., Boogerd, W., Wall, E., Droogleever Fortuyn M. & Rodenhuis S. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose vs standard-dose chemotherapy. Journal of the National Cancer Institute, 90, 210-218.
29. Valentine, A. & Meyers, C. (2001). Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer, 92, 1694-1698.
30. Wieneke, M. & Dienst, E. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.